𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Trilostane in the treatment of advanced breast cancer

✍ Scribed by C. G. Beardwell; A. C. Hindley; P. M. Wilkinson; I. D. H. Todd; G. G. Ribeiro; d. Bu'Lock

Publisher
Springer
Year
1983
Tongue
English
Weight
284 KB
Volume
10
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of advanced male breast cancer
Treatment of advanced male breast cancer
✍ William G. Kraybill; Richard Kaufman; David Kinne πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 434 KB πŸ‘ 2 views

The modalities used to treat 27 male patients with metastatic breast cancer at Memorial Hospital from 1957-1979 are reviewed. The overall objective orchiectomy response rate was 48% (11123). The median response was 11 months (6-96 months). The median survival in responders was 58 months, whereas the

Combination chemotherapy in the treatmen
Combination chemotherapy in the treatment of advanced breast cancer
✍ Dutzu Rosner; Takuma Nemoto; Chief Thomas L. Dao πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 289 KB

## Abstract Seventy‐two women with metastatic breast cancer were treated with multiple‐agent chemotherapy. Fifty women were treated with 5 drugs in combination: 5‐FU, methotrexate, vincristine, cytoxan, and prednisone; 22 were treated with the combination of 3 drugs: 5‐FU, cytoxan, and prednisone.